COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report
Open Access
- 29 October 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 114, 178-182
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escapeScience, 2021
- SARS-CoV-2 evolution during treatment of chronic infectionNature, 2021
- Emergence of multiple SARS-CoV-2 mutations in an immunocompromised hostmedRxiv, 2021
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Nature Communications, 2021
- Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinityBiochemical and Biophysical Research Communications, 2021
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostNew England Journal of Medicine, 2020
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with CancerCell, 2020
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusionNature, 2020
- Temporal signal and the phylodynamic threshold of SARS-CoV-2Virus Evolution, 2020
- Real-time PCR-based SARS-CoV-2 detection in Canadian laboratoriesJournal of Clinical Virology, 2020